BacterOMIC

Warsaw, Poland Founded: 2017 • Age: 9 yrs
Developer of a system for antibiotic susceptibility testing
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 3 Brand Intelligence

About BacterOMIC

BacterOMIC is a company based in Warsaw (Poland) founded in 2017. BacterOMIC offers products and services including BACTEROMIC System, Universal Panel, and Custom AST Panel. BacterOMIC operates in a competitive market with competitors including Rapid Micro Biosystems and Rapiddx Technologies, among others.

  • Headquarter Warsaw, Poland
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Bacteromic Spółka Z Ograniczoną Odpowiedzialnością
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
    -$369.7 K (USD)
    15
    as on Dec 31, 2020
  • EBITDA
    $3.14 K (USD)
    -42
    as on Dec 31, 2020
  • Latest Funding Round
    $2.13 M (USD), Grant

    Aug 01, 2019

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of BacterOMIC

BacterOMIC offers a comprehensive portfolio of products and services, including BACTEROMIC System, Universal Panel, and Custom AST Panel.

Primary

Evaluates antibiotic effectiveness against bacterial infections.

Assesses susceptibility directly from positive blood cultures.

Provides tailored testing for animal pathogen resistance.

People of BacterOMIC

Headcount 10-50
Employee Profiles 4
Employee Profiles
People
Bernd Eberhardt
CEO
People
Szymon Ruta
Chief Financial Officer
People
Anna S.
Manager Ds. Finansowych
People
Łukasz Richter
Product Manager

Unlock access to complete

Funding Insights of BacterOMIC

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $2.1M
  • First Round

    (01 Aug 2019)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2019 Amount Grant - BacterOMIC Valuation

investors

Investors in BacterOMIC

BacterOMIC has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location

Investments & Acquisitions by BacterOMIC

Investments

Financial Statements - BacterOMIC

Bacteromic Comparisons

+
Add Comparison
Available on Premium

Competitors of BacterOMIC

BacterOMIC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Micro Biosystems and Rapiddx Technologies, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biosystems for microbial contamination detection are developed and supplied.
domain founded_year HQ Location
Antimicrobial susceptibility platform is developed via microfluidics and sensor technology.

Latest news on Bacteromic

Frequently Asked Questions about BacterOMIC

BacterOMIC was founded in 2017 and raised its 1st funding round 2 years after it was founded.

BacterOMIC is headquartered in Warsaw, Poland.

Developer of a system for antibiotic susceptibility testing. The system has a disposable panel that contains various antibiotics and a checkerboard combination of antibiotics. It is developed by combining microfluidics, detection, data analysis, and automation which helps in determining the treatment of MDR pathogens.

BacterOMIC's top competitors include Rapid Micro Biosystems and Rapiddx Technologies.

BacterOMIC offers BACTEROMIC System, Universal Panel, and Custom AST Panel.

BacterOMIC has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available